What is the dosage comparison between Trulicity (dulaglutide) pen and semaglutide 1 mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Dosage Comparison

Trulicity (dulaglutide) pen is administered at a dose of 0.75 mg subcutaneously once weekly, which can be titrated to 1.5 mg once weekly for additional glycemic control 1, whereas semaglutide is administered at a dose of 0.25 mg subcutaneously once weekly, which can be increased to 0.5 mg and then to 1 mg once weekly for glycemic control 1.

  • The recommended dosing for Trulicity is 0.75 mg or 1.5 mg subcutaneously once weekly 1.
  • The recommended dosing for semaglutide is 0.25 mg, 0.5 mg, or 1 mg subcutaneously once weekly 1.
  • It's worth noting that semaglutide also has an oral formulation, which is administered at a dose of 3 mg once daily, but this is not directly comparable to the subcutaneous formulation of Trulicity 1.
  • The dosing regimens for both medications are designed to provide a sustained release of the active ingredient over a period of time, with Trulicity providing a 7-day release and semaglutide providing a weekly release 1.
  • The 1 mg daily dose of semaglutide is not a standard dosing regimen for this medication, as it is typically administered once weekly for the treatment of type 2 diabetes 1.

From the Research

Dosage Comparison

  • The dosage of Trulicity (dulaglutide) pen is 0.75 or 1.5 mg once weekly 2, 3.
  • Semaglutide is available in different formulations, including a once-weekly subcutaneous injection and a daily oral preparation 4, 5, 6.
  • The daily oral preparation of semaglutide is taken at a dose of 1 mg daily, but the study does not provide a direct comparison with the dulaglutide pen dosage 4.
  • It is essential to note that the dosages of dulaglutide and semaglutide are not directly comparable due to their different formulations and administration routes.

Key Differences

  • Dulaglutide is administered once weekly, while semaglutide has both once-weekly and daily oral formulations 2, 4, 3, 5, 6.
  • The primary pharmacodynamic difference between short-acting and long-acting GLP-1 RAs, such as dulaglutide and semaglutide, is their effect on fasting glucose and postprandial glucose 5.

Administration Routes

  • Dulaglutide is administered subcutaneously once weekly 2, 3.
  • Semaglutide is available in both subcutaneous and oral formulations, with the oral preparation taken daily 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dulaglutide: A Review in Type 2 Diabetes.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.